Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04536792
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

Who this might be right for
Healthy VolunteersAnemia, Sickle Cell
Agios Pharmaceuticals, Inc. 122
Not applicableLooking for participantsNCT04745195
What this trial is testing

Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium

Who this might be right for
Thrombotic MicroangiopathiesHemolytic Uremic Syndrome, AtypicalHemolytic-Uremic Syndrome
Maastricht University Medical Center 42
Not applicableLooking for participantsNCT06944067
What this trial is testing

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
National Human Genome Research Institute (NHGRI) 50
Not applicableEnded earlyNCT04156399
What this trial is testing

Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study

Who this might be right for
Sickle Cell Disease
University of Illinois at Chicago 6
Testing effectiveness (Phase 2)Study completedNCT03805581
What this trial is testing

Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome

Who this might be right for
Sickle Cell DiseaseAcute Chest Syndrome
New York Medical College 20
Testing effectiveness (Phase 2)Study completedNCT00373594
What this trial is testing

Therapy for Chronic Cold Agglutinin Disease

Who this might be right for
Cold Agglutinin Disease
University of Bergen 30
Not applicableStudy completedNCT06986837
What this trial is testing

Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient

Who this might be right for
Sickle Cell Disease
Centre Hospitalier Universitaire de la Guadeloupe 92
Large-scale testing (Phase 3)WithdrawnNCT04293172
What this trial is testing

Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.

Who this might be right for
Sickle Cell Disease
AstraZeneca
Early research (Phase 1)Study completedNCT01597401
What this trial is testing

A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Baxalta now part of Shire 19
Not applicableStudy completedNCT01569971
What this trial is testing

Adolescent, Caregiver, and Young Adult Perspectives of the Transition From Pediatric to Adult Care for Sickle Cell Disease: A Preliminary Evaluation of the Sickle Cell Disease Transition Program

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 55
Large-scale testing (Phase 3)Study completedNCT02174900
What this trial is testing

Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 70
Not applicableStudy completedNCT02069236
What this trial is testing

Comparing G6PD Tests Using Capillary Blood Versus Venous Blood

Who this might be right for
Glucose-6 Phosphate Dehydrogenase Deficiency
PATH 150
Early research (Phase 1)Looking for participantsNCT07256301
What this trial is testing

A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Who this might be right for
PNH - Paroxysmal Nocturnal Hemoglobinuria
Shanghai Lanyi Therapeutics Co., Ltd. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603557
What this trial is testing

Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)

Who this might be right for
Chronic Immune ThrombocytopeniaAutoimmune Hemolytic Anemia
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06198712
What this trial is testing

Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Forma Therapeutics, Inc. 95
Large-scale testing (Phase 3)Ended earlyNCT03040765
What this trial is testing

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)Osteoporosis
Hamad Medical Corporation 17
Not applicableStudy completedNCT00895154
What this trial is testing

A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study

Who this might be right for
Sickle Cell Disease
Washington University School of Medicine 21
Not applicableLooking for participantsNCT07206095
What this trial is testing

Integrative Diagnosis for SCD and Other RADs

Who this might be right for
Sickle Cell DiseaseThalassaemiaCongenital Dyserythropoietic Anemia (CDA)+6 more
Hospital Universitari Vall d'Hebron Research Institute 200
Testing effectiveness (Phase 2)Ended earlyNCT02013375
What this trial is testing

SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD

Who this might be right for
Sickle Cell Disease
Damiano Rondelli, MD 2
Not applicableEnded earlyNCT03387033
What this trial is testing

Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell DiseaseVirtual RealityAnxiety+2 more
Duke University 20
Next Page